Congenital heart disease (CHD) affects 8 in 1000 children and is the most common reason for serious illness in newborns and is responsible for a significant part of the work carried out in specialist children’s hospitals. Management of these children relies heavily on technology from advanced imaging and monitoring tools, to a range of technologies and devises used for key-hole interventions and surgery. Despite this, the technologies used in this group have been developed for adults. Developing technologies that are designed to meet the needs of children would therefore have substantial clinical impact to help improve diagnosis and treatment.

Our strategy focuses on the development and adoption of novel imaging and computational modelling technologies for diagnosis and treatment of children with congenital heart disease. The strategy incorporates a broad scope, from pregnancy and the developing fetus, through to children and young adults with congenital heart disease.

Some of the key areas are as follows: